# Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

> **NCT04160390** · — · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 72 (actual)

## Conditions studied

- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- Donor
- Malignant Neoplasm

## Interventions

- **OTHER:** Biospecimen Collection-Blood
- **OTHER:** Biospecimen Collection-Stool

## Key facts

- **NCT ID:** NCT04160390
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-13
- **Primary completion:** 2027-04-24
- **Final completion:** 2027-04-24
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160390, "Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04160390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*